Theresa V. Strong - Concepedia

Author

Theresa V. Strong

University of Alabama at Birmingham ORCID

Also Known As

Strong, T.V., T Strong, T V Strong, T. Strong, T. V. Strong, T.V. Strong, TV Strong, TV. Strong, Theresa Strong, Theresa V Strong

141

Publications

5.4K

Citations

H-Index

105

Concepts

All Affiliations

University of Alabama at Birmingham University of Michigan Foundation for Prader-Willi Research Howard Hughes Medical Institute Duke University

About

Theresa V. Strong is an author at University of Alabama at Birmingham specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	26	2.7K
2	Natural Sciences	4	4	247
3	Engineering	3	3	159
4	Health Sciences	1	1	355
5	Social Sciences	1	1	15

Theresa V. Strong

Publications

Citations

H-Index

Page 1

	Year	Citations
Chloride Conductance Expressed by ΔF508 and Other Mutant CFTRs In <i>Xenopus</i> Oocytes Mitchell L. Drumm, Daniel J. Wilkinson, Lisa S. Smit, Science	1991	498
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer Eben L. Rosenthal, Jason M. Warram, Esther de Boer, Clinical Cancer Research	2015	456
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues Theresa V. Strong, Danilo A. Tagle, John Valdes, Nature Genetics Genetic DisorderGeneticsDisease GeneDegenerative DiseaseNeuroscience	1993	408
Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells Jonathan A. Cohn, Theresa V. Strong, Marina R. Picciotto, Gastroenterology Molecular PhysiologySignal TransductionBiliary TractLiver PhysiologyPhysiology	1993	355
Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. Theresa V. Strong, Katharina Böehm, Francis S. Collins Journal of Clinical Investigation Protein SecretionGastroenterologyPathologyDigestive TractCellular Physiology	1994	274
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial Jawad Fares, Atique U. Ahmed, Ilya V. Ulasov, The Lancet Oncology Neuro-oncologyGliomaNeural Stem CellDose-escalation TrialRadiation Oncology	2021	191
Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Feng Wang‐Johanning, Andra R. Frost, Gary L. Johanning, PubMed Envelope RegionViral ReplicationCancer-associated VirusHuman RetrovirusImmunology	2001	179
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Ronald D. Alvarez, Mack N. Barnes, Jesús Gómez-Navarro, PubMed Gene TherapiesGene Transfer/expressionMedicineImmunologyHuman Ovarian Cancer	2000	161
Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients. Robert M. Conry, David T. Curiel, Theresa V. Strong, PubMed ImmunologyImmunoeditingPathologyImmunotherapeuticsImmunotherapy	2002	147
Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Keizo Kasono, Jerry L. Blackwell, Joanne T. Douglas, PubMed Adenoviral VectorEngineeringImmunologyGene DeliveryBiomedical Engineering	1999	134

Page 1